A NEJM study estimates that 2 percent of all cancers in the next 20 to 30 years may be attributable to CT scans.
The price of overtesting and defensive medicine has just gone up.
More testing does not always equate to better medicine.
A NEJM study estimates that 2 percent of all cancers in the next 20 to 30 years may be attributable to CT scans.
The price of overtesting and defensive medicine has just gone up.
More testing does not always equate to better medicine.
Free, and one click to unsubscribe.
Be civil and stay on topic. Your first comment is reviewed before it appears. Comments that break our comment policy are removed.
Free, and one click to unsubscribe.